CDXC - נזילות מהירה ChromaDex

ChromaDex Corporation (CDXC) generates revenue by creating nutritional components, ensuring a steady cash flow through retail trade. This price chart on GURU.Markets, where the liquidity ratio is 3.14, confirms the effectiveness of implementing AI systems and packaging automation at its plants. Business development relies on global B2B raw material supply agreements without engaging in merger and acquisition deals.

Tru Niagen sales through global distributors generate a steady cash flow that defines the operational resilience of ChromaDex Corporation (CDXC). This indicator compares cash and accounts receivable against short-term liabilities, completely excluding illiquid inventories. The investor assesses the company's ability to immediately settle debts without an emergency liquidation of stock. Analyzing the critical assessment ratio helps identify the risk of cash flow gaps and the overall financial security of the business.